ACADIA Pharmaceuticals, Inc. (ACAD)
29.63
+0.13
(+0.44%)
USD |
NASDAQ |
Aug 24, 16:00
29.63
0.00 (0.00%)
After-Hours: 19:20
ACADIA Pharmaceuticals Price to Book Value : 3.903 for Aug. 24, 2026
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| August 21, 2026 | 3.886 |
| August 20, 2026 | 3.826 |
| August 19, 2026 | 3.980 |
| August 18, 2026 | 3.976 |
| August 17, 2026 | 3.822 |
| August 14, 2026 | 3.720 |
| August 13, 2026 | 3.739 |
| August 12, 2026 | 3.880 |
| August 11, 2026 | 3.874 |
| August 10, 2026 | 3.872 |
| August 07, 2026 | 3.848 |
| August 06, 2026 | 3.748 |
| August 05, 2026 | 3.794 |
| August 04, 2026 | 3.577 |
| August 03, 2026 | 3.374 |
| July 31, 2026 | 3.408 |
| July 30, 2026 | 3.498 |
| July 29, 2026 | 3.47 |
| July 28, 2026 | 3.427 |
| July 27, 2026 | 3.345 |
| July 24, 2026 | 3.272 |
| July 23, 2026 | 3.271 |
| July 22, 2026 | 3.288 |
| July 21, 2026 | 3.350 |
| July 20, 2026 | 3.305 |
| Date | Value |
|---|---|
| July 17, 2026 | 3.372 |
| July 16, 2026 | 3.376 |
| July 15, 2026 | 3.415 |
| July 14, 2026 | 3.358 |
| July 13, 2026 | 3.359 |
| July 10, 2026 | 3.454 |
| July 09, 2026 | 3.479 |
| July 08, 2026 | 3.425 |
| July 07, 2026 | 3.452 |
| July 06, 2026 | 3.395 |
| July 02, 2026 | 3.421 |
| July 01, 2026 | 3.320 |
| June 30, 2026 | 3.333 |
| June 29, 2026 | 3.454 |
| June 26, 2026 | 3.471 |
| June 25, 2026 | 3.252 |
| June 24, 2026 | 3.202 |
| June 23, 2026 | 3.098 |
| June 22, 2026 | 3.028 |
| June 18, 2026 | 2.964 |
| June 17, 2026 | 2.961 |
| June 16, 2026 | 2.870 |
| June 15, 2026 | 2.915 |
| June 12, 2026 | 2.891 |
| June 11, 2026 | 2.932 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Incyte Corp. | 4.054 |
| Agios Pharmaceuticals, Inc. | 1.894 |
| Biogen, Inc. | 1.709 |
| Insmed, Inc. | 35.74 |
| Vertex Pharmaceuticals, Inc. | 6.854 |
Price to Book Value Related Metrics
| PE Ratio | 13.34 |
| PS Ratio | 4.473 |
| PEG Ratio | 0.1997 |
| Price to Free Cash Flow | 34.97 |
| Price | 29.63 |
| Earnings Yield | 7.49% |
| Market Cap | 5.100B |
| PEGY Ratio | 0.1997 |
| Operating PE Ratio | 58.97 |
| Normalized PE Ratio | 13.34 |